Daiichi Sankyo

NCT07474649

Phase 3Not yet recruiting103 people16 Mar 2026clinicaltrials.gov

NCT07268625

Phase 1Completed58 people8 Dec 2025clinicaltrials.gov

NCT07235189

Phase 1Completed58 people19 Nov 2025clinicaltrials.gov

NCT07201545

Phase 1Completed58 people1 Oct 2025clinicaltrials.gov

NCT07182383

Phase 1Completed58 people19 Sept 2025clinicaltrials.gov

NCT07129993

Phase 2/3Recruiting630 people19 Aug 2025clinicaltrials.gov

NCT07022483

Phase 3Recruiting710 people15 Jun 2025clinicaltrials.gov

NCT06925100

Phase 4Completed180 people13 Apr 2025clinicaltrials.gov

NCT06797635

CollaboratorPhase 2Recruiting372 people28 Jan 2025clinicaltrials.gov

NCT06578247

Phase 3Active, not recruiting700 people29 Aug 2024clinicaltrials.gov

NCT06564844

CollaboratorPhase 3Active, not recruiting25 people21 Aug 2024clinicaltrials.gov

NCT06417814

CollaboratorPhase 3Recruiting744 people16 May 2024clinicaltrials.gov

NCT06402851

CollaboratorPhase 4Recruiting1,500 people7 May 2024clinicaltrials.gov

NCT06112379

CollaboratorPhase 3Active, not recruiting1,902 people1 Nov 2023clinicaltrials.gov

NCT05555732

Phase 3Active, not recruiting1,170 people27 Sept 2022clinicaltrials.gov

NCT05113251

CollaboratorPhase 3Active, not recruiting927 people9 Nov 2021clinicaltrials.gov

NCT05048797

CollaboratorPhase 3Active, not recruiting454 people17 Sept 2021clinicaltrials.gov

NCT04730037

CollaboratorPhase 3Completed74 people29 Jan 2021clinicaltrials.gov

NCT04686305

CollaboratorPhase 1Recruiting304 people28 Dec 2020clinicaltrials.gov

NCT04379596

CollaboratorPhase 2Active, not recruiting452 people7 May 2020clinicaltrials.gov

Clinical Outcomes According to Age and Atrial Fibrillation Type: Insights from the Multicentre REGUEIFA Registry

19 Sept 2026api.crossref.org